New World Investor – Technology Stocks and More » US Food and Drug Administration

Sep

24

Radar Report – 9.24.09

Michael Murphy Radar Reports 142 comments

Read the rest of this entry

Amgen, Arena Pharmaceuticals, Clinical trial, Dendreon, Health, US Food and Drug Administration, Weight loss

Sep

20

Flash Alert – BCRX Posted to Seeking Alpha – 9.20.09

Michael Murphy Flash Alerts 54 comments

Read the rest of this entry

BioCryst, Clinical trial, Great Britain, intravenous antiviral, peramivir, San Francisco, Swine influenza, United States, United States Department of Health and Human Services, US Food and Drug Administration, World Health Organization

Sep

18

Flash Alert – Arena Hits All Targets – 9.18.09

Michael Murphy Radar Reports 42 comments

Read the rest of this entry

Anti-obesity medication, Body weight, Clinical trial, Contrave, Fen-phen, Health, lorcaserin, Qnexa, US Food and Drug Administration, Weight loss

Sep

15

Flash Alert – BCRX Up Sharply On Partnerships

Michael Murphy Uncategorized 258 comments

Read the rest of this entry

BioCryst, Brazil, China, Infectious disease, Influenza outbreak, Mexico, Oseltamivir, peramivir, swine flu, United States, US Food and Drug Administration

Sep

14

Flash Alert – $2K to $1M Trades – 9.14.09

Michael Murphy Flash Alerts 95 comments

Read the rest of this entry

Arena Pharmaceuticals, Clinical trial, Dendreon, DNDN, NASDAQ, Obesity, Statistical significance, US Food and Drug Administration

Sep

02

Flash Alert – 9.2.09 – Raising BCRX Buy Limit

Michael Murphy Flash Alerts 67 comments

The bear raid on BioCryst (BCRX) ran

Read the rest of this entry

Exponential growth, FDA, Infectious disease, Swine influenza, Twitter, United States, US, US Food and Drug Administration

Sep

01

Flash Alert – Market and BioCryst – 9.1.09

Michael Murphy Flash Alerts 33 comments

Dear New World Investor:

Fractal analysis showed

Read the rest of this entry

American Association of Individual Investors, Business, Dendreon, Oseltamivir, Swine influenza, US Food and Drug Administration, Yahoo, Zanamivir

Aug

14

Flash Alert – BCRX Files Two Phase III Trials

Michael Murphy Flash Alerts 55 comments

BioCryst (BCRX) has filed for two Phase III clinical trials for peramivir,

Read the rest of this entry

Clinical trial, FDA, Health, Infectious disease, Influenza, Oseltamivir, Statistical significance, US Food and Drug Administration

S&P 500	1344.90	+19.36
NASDAQ	2905.66	+45.98
DX-Y.NYB	78.942	-0.049
GCG12.CMX	1725.10	-31.7001

Radar Report – 9.24.09

Flash Alert – BCRX Posted to Seeking Alpha – 9.20.09

Flash Alert – Arena Hits All Targets – 9.18.09

Flash Alert – BCRX Up Sharply On Partnerships

Flash Alert – $2K to $1M Trades – 9.14.09

Flash Alert – 9.2.09 – Raising BCRX Buy Limit

Flash Alert – Market and BioCryst – 9.1.09

Flash Alert – BCRX Files Two Phase III Trials

Login Status

Purchase Michael's Book on Amazon

Index Quotes

Member Resources

Recent Posts

Free Content

Categories

Latest Posts on the Forum

Archives